IRIS
PICCOLO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.650
NA - Nord America 4.542
EU - Europa 3.570
SA - Sud America 737
AF - Africa 174
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.339
SG - Singapore 2.993
RU - Federazione Russa 1.704
CN - Cina 1.282
VN - Vietnam 1.113
BR - Brasile 592
IT - Italia 586
HK - Hong Kong 541
NL - Olanda 297
FR - Francia 232
DE - Germania 223
JP - Giappone 186
GB - Regno Unito 109
CA - Canada 105
IN - India 98
KR - Corea 87
FI - Finlandia 86
BD - Bangladesh 75
IE - Irlanda 63
MX - Messico 61
AR - Argentina 51
CI - Costa d'Avorio 45
AT - Austria 40
SE - Svezia 39
BE - Belgio 33
ZA - Sudafrica 33
IQ - Iraq 31
PL - Polonia 30
PH - Filippine 29
EC - Ecuador 27
TH - Thailandia 27
ES - Italia 24
ID - Indonesia 24
PK - Pakistan 22
UA - Ucraina 22
TW - Taiwan 19
MA - Marocco 17
TR - Turchia 17
PY - Paraguay 16
KE - Kenya 15
CH - Svizzera 14
UZ - Uzbekistan 13
JO - Giordania 12
VE - Venezuela 12
EG - Egitto 11
PE - Perù 11
SA - Arabia Saudita 11
CL - Cile 10
CO - Colombia 9
AU - Australia 8
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
ET - Etiopia 8
LT - Lituania 8
TN - Tunisia 8
PS - Palestinian Territory 7
IL - Israele 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
KZ - Kazakistan 5
NG - Nigeria 5
BO - Bolivia 4
BY - Bielorussia 4
DZ - Algeria 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
JM - Giamaica 4
OM - Oman 4
PA - Panama 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
RO - Romania 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
BS - Bahamas 2
CV - Capo Verde 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
EE - Estonia 2
GN - Guinea 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
ME - Montenegro 2
MK - Macedonia 2
NE - Niger 2
Totale 15.643
Salva come PNG Salva come JPEG
Città #
Singapore 1.504
San Jose 851
Ashburn 527
Hong Kong 524
Moscow 403
Hefei 346
Ho Chi Minh City 314
Chandler 283
Hanoi 266
Amsterdam 262
Beijing 259
Naples 199
The Dalles 185
Lauterbourg 172
Tokyo 170
Santa Clara 153
Los Angeles 118
Millbury 114
Nanjing 103
New York 89
Boston 81
Des Moines 73
Redondo Beach 73
Munich 68
Seoul 68
Princeton 64
Buffalo 61
Lawrence 50
Ottawa 50
Council Bluffs 49
Da Nang 49
Dallas 49
Haiphong 46
São Paulo 46
Frankfurt am Main 45
Orem 35
Milan 33
Wilmington 31
Mexico City 30
Chicago 28
Courcelles 28
Denver 28
Nuremberg 28
Rome 28
Seattle 28
Napoli 24
Brooklyn 23
Warsaw 23
London 22
Hebei 21
Lappeenranta 19
Montreal 19
Poplar 19
Rio de Janeiro 18
Shenyang 18
Chennai 17
Houston 17
Biên Hòa 16
San Francisco 16
Brasília 15
Jiaxing 15
Phoenix 15
Stockholm 15
Tianjin 15
Toronto 15
Vienna 15
Johannesburg 14
Nanchang 14
Turku 14
Atlanta 13
Belo Horizonte 13
Boardman 13
Changsha 13
Nairobi 13
Tashkent 13
Amman 12
Helsinki 12
Hải Dương 12
Kronberg 12
Thái Nguyên 12
Afragola 11
Baghdad 11
Bengaluru 11
Columbus 11
Guayaquil 11
San Giuseppe Vesuviano 11
Can Tho 10
Manchester 10
Mumbai 10
Thái Bình 10
Buenos Aires 9
Dhaka 9
Jacksonville 9
Lahore 9
Portsmouth 9
Addis Ababa 8
Baku 8
Bắc Ninh 8
Cairo 8
Düsseldorf 8
Totale 8.759
Salva come PNG Salva come JPEG
Nome #
1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention 241
A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania, Italy 174
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 151
Application of the 2016 ASE-EACVI Criteria for the Assessment of Diastolic Function in Arterial Hypertension 146
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 142
Management of Intraventricular Gradient in Patients With Aortic Stenosis 141
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 140
Predictors of adherence to composite therapy after acute coronary syndromes 138
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 137
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 137
Title The GPIIIA PIA2 Polymorphism is Associated with an Increased Risk of Cardiovascular Adverse Event 136
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 135
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 134
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 133
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 133
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 132
Echocardiographic Evaluation of Aortic Stenosis: A Comprehensive Review 132
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 131
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 131
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 130
Carotid plaque offsets sex-related differences in cardiovascular risk of young hypertensive patients 130
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 130
Sex-Related Differences in Left Ventricular Geometry Patterns in Patients With Arterial Hypertension 130
A New Approach to Percutaneous Coronary Revascularization in Patients Requiring Undeferrable Non Cardiac Surgery. 129
Is There Still a Role for Invasive Assessment of Aortic Gradient? 127
Prolonged Time-to-antihypertensive Therapy Worsens Organ Damage and Blood Pressure Control in Arterial Hypertension 123
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 123
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology 121
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 120
Angiographic improvement in STEMI reperfusion: a single centre experience 120
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis. 120
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. 118
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 116
No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives. 116
New perspectives for transcatheter aortic valve implantation: more than a "simple" alternative to surgery. 116
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 115
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases 115
Adenosine-induced torsade de pointes complicating a fractional flow reserve measurement in a right coronary artery intermediate stenosis. 115
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 115
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: is the randomized evidence conclusive? 114
Correction to: Acute advanced aortic stenosis 113
[SICI-GISE/SICOA Consensus document: Clinical follow-up of patients after acute coronary syndrome or percutaneous coronary intervention] 112
Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials. 112
Pharmacotherapeutic Considerations for the Use of Prasugrel and Ticagrelor to Reduce Stent Thrombosis in Patients With Acute Coronary Syndrome. 111
Effect of drug-eluting stents in patients with acute ST-segmentelevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. 110
Harnessing Multi-modality and Expert Knowledge for Adverse Events Prediction in Clinical Notes 109
A new approach to percutaneous coronary revascularization in patients requiring undeferrable non-cardiac surgery 107
Coronary stenting early before non-cardiac surgery: is the endothelial progenitor cell capturing coronary stent a solution? 107
Sirolimus- versus paclitaxel-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 107
Reperfusion Correlates and Clinical Outcomes of Right Ventricular Dysfunction in Patients With Inferior ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention 107
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 106
Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. 106
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials. 106
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 105
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study 105
Exploring the physiologic variations and related determinants of left ventricular diastolic function among 381 healthy Caucasian adults by the 2016 American Society of Echocardiography-European Association of Cardiovascular Imaging guidelines 104
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials 104
Everolimus- versus first generation drug-eluting stents: the never-ending story of searching for a winner in the "limus family". 103
Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: The ARGENTO Study: a prospective, multicenter registry. 103
Acute advanced aortic stenosis 103
Double Inversion Technique for Multivessel Primary PCI in Dextrocardia 102
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 102
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 101
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak 101
[Debate on dual pathway inhibition: Antiplatelet therapy in patients with peripheral artery disease: old but gold?] 100
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment 100
Angiographic complexity of coronary artery disease according to syntax score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: A substudy of the bioscience trial 99
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 97
Is direct stenting superior to stenting with predilation inpatients treated with percutaneous coronary intervention? Results from a meta-analysis of 24 randomised controlled trials. 96
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 95
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the current era of new-generation DES 95
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 95
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial 93
Early stent thrombosis with bivalirudin in patients undergoing percutaneous coronary intervention. A meta-analysis of randomised clinical trials 92
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from the 2-Year Follow-Up of the BIOSCIENCE Trial 89
Relationship between changes in platelet reactivity and ischemic?events following percutaneous coronary intervention: A?meta-regression analysis of 30 randomized trials 87
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 86
CardioPulse: Different bleeding scores and which one should we use? 86
Preprocedural high-sensitivity cardiac Troponin T and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention 86
Antithrombotic therapy and vascular access site: A choice not mutually exclusive 85
Renal denervation and long-term results 84
Comparative effectiveness and safety of new-generation versus early-generation drug-eluting stents according to complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients 82
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction 82
Predicting Recurrent Restenosis After Drug-eluting Balloon: A First Step Toward Personalized Treatment 82
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 82
Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates 81
What About Pharmacologic Therapy? 81
A new approach to percutaneous coronary revascoularization in patient requiring undeferrable non-cardiac surgery. 80
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 80
Effect of an invasive strategy on outcome in patients ≥75 years of age with non-St-elevation acute coronary syndrome 80
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 80
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection 79
Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure. 78
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial 78
Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacement 78
Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries: A Network Meta-Analysis 78
The ultimaster biodegradable-polymer sirolimus-eluting stent: An updated review of clinical evidence 77
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 75
Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: A meta-analysis of randomized trials 74
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 73
Totale 10.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 13 5
2021/2022491 4 1 8 1 1 21 2 19 89 6 62 277
2022/2023894 122 63 21 56 94 76 6 49 109 226 62 10
2023/2024683 22 128 114 36 26 25 15 89 19 26 116 67
2024/20254.095 190 212 16 41 107 157 506 252 394 420 1.417 383
2025/20269.131 880 740 839 973 1.461 474 926 748 1.224 627 239 0
Totale 15.914